Harmin Chima, OD, met with Optometry Times to discuss treatment options for ocular surface disease with Biovance's 3-layer amniotic membrane graft.
Harmin Chima, OD
Advertisement
Articles by Harmin Chima, OD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
AAOpt 2025 recap: ODs provide new clinical findings on dry eye
2
Regeneron receives another CRL for its Eylea 8 mg
3
Application period opens for 2026 Golden Opportunity Award to support emerging optometrists
4
Latinos en Optometry highlights importance of language access in eye care in new blog on interpreter and translation services
5
.png "Optometry Times"){kind=logo}
